These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2059827)

  • 1. Development and reversibility of T lymphocyte dysfunction in experimental obstructive jaundice.
    Gouma DJ; Greve JW; Bemelmans MH
    Br J Surg; 1991 May; 78(5):633. PubMed ID: 2059827
    [No Abstract]   [Full Text] [Related]  

  • 2. Development and reversibility of T lymphocyte dysfunction in experimental obstructive jaundice.
    Thompson RL; Hoper M; Diamond T; Rowlands BJ
    Br J Surg; 1990 Nov; 77(11):1229-32. PubMed ID: 2253000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human lymphocyte responsiveness is not enhanced by relief of biliary obstruction: an in-vitro study.
    Pace RF; Gonzaga R; Kaminski E; Hodgson HJ; Benjamin IS
    Can J Surg; 1991 Apr; 34(2):123-7. PubMed ID: 2025801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Internal biliary drainage improves decreased number of gut mucosal T lymphocytes and MAdCAM-1 expression in jaundiced rats.
    Sano T; Ajiki T; Takeyama Y; Kuroda Y
    Surgery; 2004 Sep; 136(3):693-9. PubMed ID: 15349120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [T-cell immunity in obstructive jaundice of tumor etiology].
    Masalin MM; Orazbekov NI
    Klin Khir (1962); 1985; (9):29-31. PubMed ID: 3877208
    [No Abstract]   [Full Text] [Related]  

  • 6. T-lymphocyte transformation in experimental obstructive jaundice: the role of serum-suppressive factors.
    Thompson RL; Ranjbar S; Rowlands BJ
    World J Surg; 1993; 17(6):783-5. PubMed ID: 8109118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of cellular immunity in obstructive jaundice is caused by endotoxins: a study with germ-free rats.
    Greve JW; Gouma DJ; Soeters PB; Buurman WA
    Gastroenterology; 1990 Feb; 98(2):478-85. PubMed ID: 2295404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The immune changes in the patient with obstructive jaundice: their onset and reversibility after drainage].
    Rodolico A; Morini S; Di Bernardo C; Amoroso S; Fodale P; Vaccaro B
    Minerva Chir; 1994 Dec; 49(12):1195-204. PubMed ID: 7746438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of host-versus-graft response in experimental biliary obstruction.
    Roughneen PT; Kulkarni AD; Gouma DJ; Fanslow WC; Rowlands BJ
    Transplantation; 1986 Dec; 42(6):687-9. PubMed ID: 3491451
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cellular immunity in obstructive jaundice of cholelithic etiology].
    Masalin MM; Zelentsova OA; Orazbekov NI
    Klin Khir (1962); 1984 Sep; (9):15-8. PubMed ID: 6333546
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of obstructive jaundice on immunocompetence in jaundiced patients].
    Wang QH
    Zhonghua Wai Ke Za Zhi; 1993 Mar; 31(3):148-52. PubMed ID: 8223024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biliary decompression promotes Kupffer cell recovery in obstructive jaundice.
    Clements WD; McCaigue M; Erwin P; Halliday I; Rowlands BJ
    Gut; 1996 Jun; 38(6):925-31. PubMed ID: 8984035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The immunological changes and prognosis of cholestatic jaundice in choledocholithiasis].
    Petrova D; Kolarski V; Todorov A; Slavchev B; Mikhaĭlova A; Dzhonova D; Todorov T
    Khirurgiia (Sofiia); 1999; 54(1):15-9. PubMed ID: 10878880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nutritional and immunological assessment in patients with malignant obstructive jaundice--the influence of preoperative biliary decompression and abdominal surgery].
    Ishida Y; Nagao T; Uchida H
    Nihon Geka Gakkai Zasshi; 1994 Feb; 95(2):71-82. PubMed ID: 8121389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-TNF-alpha treatment and bile duct drainage restore cellular immunity and prevent tissue injury in experimental obstructive jaundice.
    Padillo FJ; Cruz A; Segura-Jiménez I; Ruiz-Rabelo J; Vázquez-Ezquerra MR; Perea-Alvarez MD; Peña J; Briceño J; Muntané J
    Int J Immunopathol Pharmacol; 2007; 20(4):855-60. PubMed ID: 18179761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host immune responses and intestinal permeability in patients with jaundice.
    Parks RW; Halliday MI; McCrory DC; Erwin P; Smye M; Diamond T; Rowlands BJ
    Br J Surg; 2003 Feb; 90(2):239-45. PubMed ID: 12555304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Value of preoperative drainage of the bile ducts in obstructive jaundice].
    Gignoux BM; Blanchet MC; Baulieux J
    Ann Chir; 1999; 53(7):605-11. PubMed ID: 10520500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative external biliary drainage in obstructive jaundice. A prospective controlled clinical trial.
    Hatfield AR; Tobias R; Terblanche J; Girdwood AH; Fataar S; Harries-Jones R; Kernoff L; Marks IN
    Lancet; 1982 Oct; 2(8304):896-9. PubMed ID: 6126752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endotoxemia and intestinal mucosal dysfunction after the relief of obstructive jaundice by internal and external drainage in rats.
    Saitoh N; Hiraoka T; Uchino R; Miyauchi Y
    Eur Surg Res; 1995; 27(1):11-8. PubMed ID: 7890000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological perspectives on pancreatic cancer and jaundice.
    Monson JR; Guillou PJ
    Hepatogastroenterology; 1989 Dec; 36(6):437-41. PubMed ID: 2693298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.